Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-11T10:36:34.210Z Has data issue: false hasContentIssue false

History of Health Technology Assessment in Iran

Published online by Cambridge University Press:  13 January 2020

Morteza Arab-Zozani*
Affiliation:
Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
Mobin Sokhanvar
Affiliation:
Department of Health Services Management, Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
Edris Kakemam
Affiliation:
Department of Health Services Management, Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
Tahereh Didehban
Affiliation:
Research Expert, National Institute for Health research, Tehran university of Medical Sciences, Tehran, Iran
Soheil Hassanipour
Affiliation:
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
*
Author for Corespondence Morteza Arab-zozani E-mail: arab.hta@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

This article describes the characteristics of the health system and reviews the history of health technology assessment (HTA) in Iran, including its inception, processes, challenges, and lessons learned. This study was conducted by analyzing existing documents, reports, and guidelines related to HTA and published articles in the field. HTA in Iran has been established since the late 2000s and was first introduced as a secretariat by the Deputy of Health at the Ministry of Health and Medical Education. The mission of the HTA office is to systematically assess technologies to improve evidence-informed decision making. Despite its 10 years of existence, HTA in Iran still faces some challenges. The most pressing problems currently facing HTA in Iran include conflicts of interest among researchers performing the HTAs, the absence of a systematic structure for identifying and introducing new technologies, the lack of interest in HTA results among high-level policy makers, and the lack of external oversight for HTA projects.

Type
Article Commentary
Copyright
Copyright © Cambridge University Press 2020

Overview of the Iranian Health System

Structure

Iran is a developing country with a population of about 79 million distributed across thirty-one provinces. In 2016, its total gross domestic product (GDP) was (current US$) 418.98 billion (1). Financing and service provision in Iranian health care follows a public cooperative system with a hybrid model structure (Reference Yazdani and Jadidfard2). In 1986, medical education was integrated into the Ministry of Health, which was renamed the Ministry of Health and Medical Education (MoHME), to establish a more coordinated approach to healthcare provision and medical education (Reference Lankarani, Alavian and Peymani3).

The health system is organized across three levels: national, provincial (regional), and district (Figure 1). At the national level, the MoHME is responsible for public health, medical treatment, and medical education (Reference Yazdani and Jadidfard2). At the provincial level, the MoHME delegates its responsibilities to medical universities, of which there is at least one in every province. At the district level, public health and medical treatment are delegated to healthcare networks. At this level, education is solely related to public education, in-service training, and the training of local healthcare workers (Behvarz) (Reference Mehrdad4).

Fig. 1. Schematic structure of the Iranian health system.

Funding

Healthcare financing in Iran does not follow any defined pattern, and different government, private, and charity sectors participate in the system (Reference Davari, Haycox and Walley5). The three main sources of funding in the health system are the public budget, social health insurance, and out-of-pocket payment (Reference Davari, Haycox and Walley6). The total health expenditure has risen from 4.6 percent of the GDP in 2000 to 6.9 percent in 2016; 41 percent of the latter being contributed by public resources (1;7). There are four main public health insurance schemes in Iran: the Social Security Insurance Organization, the Medical Services Insurance Organization, the Armed Forces Medical Services Insurance Organization, and the Emdade-Emam Committee Health Insurance (Reference Davari, Haycox and Walley5).

Provision of Services

The healthcare delivery system in Iran consists of three levels: primary, secondary, and tertiary. Primary health care is provided by approximately 2,000 rural and urban health centers. In addition to providing primary care, these centers supervise the activities of rural health houses and urban health posts. Basic healthcare services in rural areas are provided by local health workers (Behvarz) (Reference Jadidfard, Yazdani and Khoshnevisan8). Secondary and tertiary healthcare services are based in urban areas and are limited to the 900 general and teaching hospitals. The government funds 554 of these hospitals, which are administrated by medical universities under the supervision of the MoHME (Reference Doshmangir, Rashidian and Jafari9).

Payment of Healthcare Professionals

At the primary care level, family physicians' fees are based on capitation and a bonus scheme for special cases (Reference Takian, Doshmangir and Rashidian10). Other members of the healthcare teams (e.g., midwives and health specialists) receive a monthly salary. At the secondary and tertiary levels, a combination of monthly salary and fee-for-service payment is used (Reference Davari, Haycox and Walley6).

Health Technology Assessment (HTA) in Iran

Health technologies produce many improvements in patient care and quality of life (Reference Arab-Zozani, Bagheri Faradonbeh and Jaafari Pooyan11). There are, however, significant concerns about adopting new technologies, including their impact on healthcare expenditures and end-user expectations. Over the last decade, these concerns have led to an increased interest in HTA in Iran (Reference Raftery, Young and Stanton12). HTA is a form of policy research that seeks to couple evidence with decision making. It examines the short- and long-term consequences of implementing a health technology (13;14) (equipment, drugs, procedures, and organizational and support systems) by assessing its effectiveness, safety, efficacy, and cost-effectiveness, as well as relevant organizational, social, ethical, and legal implications (Reference Chalkidou, Li and Culyer15). In this report, we describe the 10-year history of the HTA program in Iran, including its accomplishments and implementation challenges.

Genesis

Iran's health system has experienced profound changes in recent decades, particularly in how health technologies enter the system. During the 1960s and 1970s, new health technologies were introduced without scientific assessment. Recently, there has been increased scrutiny of advanced health technologies, and HTA is now seen as an important step in controlling the entry of new technologies into the health system (Reference Carlsson16).

HTA has been discussed in Iran since the late 1990s. In October 2007, an HTA secretariat was officially formed in the Department of Health Economics, Center for Network Development and Health Promotion within the MoHME (17;18). In the beginning, HTAs were conducted by trained faculty members from the medical universities at the request of the secretariat. In 2010, the HTA office was moved to the Heath Technology Assessment, Standardization, and Tariff Department under the Deputy of Curative Affairs in the MoHME (Reference Arab-Zozani, Jalilian and Oskouei19).

An HTA infrastructure has been established in all universities that teach medical sciences. The mission of the HTA office is to assess technologies using a systematic process, with the aim of promoting evidence-informed decision making. At first, the HTAs mainly evaluated capital equipment, but with increasing experience and expansion of research capacities in the universities and research centers, more generalized assessments were undertaken of noncapital equipment, as well as new and older technologies (Reference Doaee, Oliyaeemanesh and Nejati17;Reference Doaee, Olyaeemanesh and Emami18;Reference Olyaeemanesh, Doaee and Mohammadreza20).

Thus, the development of HTA in Iran comprised five steps: identifying graduates trained in HTA in Iran and other countries; establishing an HTA Scientific Committee; selecting the first topics for assessment; developing regulations that use HTA results to determine approvals for the introduction of costly medical equipment (>US$50,000) into the health system; and partnering with research deputies in the medical science universities to conduct HTA projects and health system research (Reference Doaee, Oliyaeemanesh and Nejati17;Reference Arab-Zozani, Majdzadeh and Sarbakhsh21).

Creation of a National Model

A secretariat was set up to carry out several tasks including receiving topics from universities applying for technology entry; prioritizing topics; calling for project orders; ordering, following up, and sponsoring the projects; running the Scientific Committee and tracking its decisions; writing, publishing, and disseminating reports; and preparing executive instructions based on the outcomes of the projects. Initially, three types of evaluations were conducted: Type I known as Elementary; Type II known as Medium; and Type III known as Excellent. The stages, duration, and required credits for each of these evaluations are provided in Supplementary Table 1.

In the early years, assessments were not comprehensive and generally only assessed the safety and effectiveness of a technology. However, the need for HTA within the health system expanded to service providers, policy makers, researchers, lawmakers, managers, pharmaceutical and medical equipment companies, and patients. At the same time, the HTA Core Model became the world's leading HTA framework (Reference Mehrdad4). Therefore, the HTA Office, in collaboration with the Center for Development of Medical Education of Shahid Beheshti University of Medical Sciences, designed and created a local HTA model for Iran, in the form of a book, over a period of 11 months (Reference Davari, Haycox and Walley5).

The model outlined the following nine aspects of a health technology that can be examined: health problems, technology recognition, safety, effectiveness, ethical, economic, organizational, social, and legal. There is a separate chapter in the book for each aspect as well as descriptive tables that provide a complete guide for researchers in the field of HTA (Reference Yazdani and Jadidfard2). Guidance on defining the topic, drafting the research questions, and collecting the necessary data is provided for each of the nine domains. A list of the domains, topics, and questions that have been examined using the present model are presented in Table 1. For further details about questions on each domain, please refer to Supplement 2.

Table 1. Number of domains, topics, and questions

Horizon Scanning

It is expected that the collaborative and voluntary research centers (Clinical Knowledge Management Centers) assess emerging health technologies to facilitate dissemination and use of horizon scanning knowledge in the country's HTA area. In doing so, these centers can promote the use of effective and preferred modern technologies in Iran. Consequently, the HTA Secretariat has developed regulations that cover the interactions between the HTA secretariat and the horizon scanning centers with respect to staffing, training, reporting, priority setting, and evaluation (see Supplement 3).

Capacity Building

In Iran, education in HTA has been promoted by holding short-term courses, workshops, and seminars. So far, ten training courses and workshops have been held in medical science universities and numerous lectures on economic evaluation and HTA have been conducted. In addition, a master's program in HTA was started in 2010, and admissions have been increasing rapidly each year since (Reference Arab-Zozani, Majdzadeh and Sarbakhsh21). At present, four campuses (Tehran University of Medical Sciences, Iran University of Medical Sciences, Yazd University of Medical Sciences, and Kerman University of Medical Sciences) have received permission to train students in this field (approximately twenty students annually). Graduates are active in HTA offices within the medical science universities as well as the partner research centers.

HTA Projects

The first HTA project conducted assessed the use of positron emission tomography scanning for the screening, diagnosis, treatment, and follow-up of cancer. Other projects included assessing dual-source computed tomography scanning and 3 Tesla magnetic resonance imaging for diagnosing diseases, hyperbaric oxygen therapy for treating diabetic foot ulcers, halothane for anesthesia, and high-intensity focused ultrasound for treating prostate cancer. According to the Iranian National Institutes of Health Research (NIHR), the number of completed projects for years 2014, 2015, 2016, and 2017 were 17, 8, 14, and 23, respectively. The most common topic areas were diagnostic devices, drugs, and surgical devices.

All phases of an HTA project, from beginning to end, are managed by the NIHR. The NIHR announces HTA projects on their Web site and researchers from universities and research centers submit proposals for each project using a standardized form. The work process for HTA projects is shown in Figure 2.

Fig. 2. Work process of health technology assessment projects.

Barriers and Facilitators

Since its inception, HTA in Iran and elsewhere has always been a challenging endeavor. Some studies have examined these challenges using quantitative and qualitative methods of research (Reference Mohtasham, Yazdizadeh and Zali22Reference Yazdizadeh, Shahmoradi and Majdzadeh24). The main challenges in implementing HTA fall into four broad categories: infrastructure, policy making and regulation, implementation processes, and internal/external stakeholders (Figure 3). Potential solutions and facilitators in the field of infrastructure include establishing an independent entity for managing conflicts of interest in the HTA process and facilitating access to existing data or, potentiality, collecting data at a national level. Legislation is suggested to facilitate decision making through partnerships among policy makers, clinicians, and patients and ensure that all stakeholders benefit from the results of HTA projects. To improve implementation, a systematic approach to HTA is suggested that includes creating multidisciplinary teams of experts in HTA, with health economics, statistics, and related clinical specialties; preparing a technology roadmap based on horizon scanning results; appraising the quality of the HTA projects; and using a standardized reporting format. These solutions may help address the challenges related to stakeholders, and to developing knowledge and awareness of HTA and its benefits. Formulating a strategic plan to overcome barriers and increase commitment to and participation in HTA processes among all stakeholders will result in better utilization of HTA results.

Fig. 3. Challenges of HTA in Iran.

Conclusion

HTA has only a short history in Iran. While the efforts made so far have been good, there is still much room for improvement. The current system must be switched from passive to active mode. Becoming active requires ensuring that all stakeholders participate in conducting and implementing HTA projects, attracting high-level policy makers, launching an active system to identify and introduce new technologies, establishing a nongovernmental organization to carry out the projects, developing a monitoring system to improve the quality of the results, and employing HTA specialists in the design, implementation, and evaluation of all projects. Resolving existing challenges can pave the way for increasing the efficiency and transparency of the HTA process, to the ultimate benefit of the health system and its stakeholders.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S0266462319003489

References

World Bank Data (2016) Iran, Islamic Rep. Available at: http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS/countries/IR?display=graph. Accessed 6 May 2016.Google Scholar
Yazdani, Sh, Jadidfard, M (2017) Developing a decision support system to link health technology assessment (HTA) reports to the health system policies in Iran. Health Policy Plan 32, 504515.Google ScholarPubMed
Lankarani, K, Alavian, M, Peymani, P (2013) Health in the Islamic Republic of Iran, challenges and progresses. Med J Islam Repub Iran 27, 4249.Google ScholarPubMed
Mehrdad, R (2009) Health system in Iran. JAMA 52, 6973.Google Scholar
Davari, M, Haycox, A, Walley, T (2012) The Iranian health insurance system; past experiences, present challenges and future strategies. Iran J Public Health 41, 19.Google ScholarPubMed
Davari, M, Haycox, A, Walley, T (2012) Health care financing in Iran; is privatization a good solution? Iran J Public Health 41, 1423.Google ScholarPubMed
World Health Organization (2014) Global status report on alcohol and health. Switzerland: World Health Organization. Available at: https://www.who.int/substance_abuse/publications/alcohol_2014/en/.Google Scholar
Jadidfard, MP, Yazdani, S, Khoshnevisan, MH (2013) Developing a policy guidance for financing dental care in Iran using the RAND Appropriateness Method. Community Dent Health 30, 227233.Google ScholarPubMed
Doshmangir, L, Rashidian, A, Jafari, M et al. (2016) Fail to prepare and you can prepare to fail: The experience of financing path changes in teaching hospitals in Iran. BMC Health Serv Res 16, 138151.CrossRefGoogle ScholarPubMed
Takian, A, Doshmangir, L, Rashidian, A (2013) Implementing family physician programme in rural Iran: Exploring the role of an existing primary health care network. Fam Pract 30, 551559.CrossRefGoogle ScholarPubMed
Arab-Zozani, M, Bagheri Faradonbeh, S, Jaafari Pooyan, E (2015) The role of health technology assessment in improving healthcare quality. J Payavard Salamat 9, 400414.Google Scholar
Raftery, J, Young, A, Stanton, L et al. . (2015) Clinical trial metadata: Defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme. Health Technol Assess 19, 1166.CrossRefGoogle ScholarPubMed
Arab Zozani, M, Amery, H, Jafari, A (2014) The role of health technology assessment in evidence-based decision making and health policy: A review study. J Health Administration 17, 99112.Google Scholar
Ciani, O, Wilcher, B, Blankart, CR et al. . (2015) Health technology assessment of medical devices: A survey of non-European union agencies. Int J Technol Assess Health Care 31, 154165.CrossRefGoogle ScholarPubMed
Chalkidou, K, Li, R, Culyer, AJ et al. (2017) Health technology assessment: Global advocacy and local realities: Comment on “priority setting for universal health coverage: We need evidence-informed deliberative processes, not just more evidence on cost-effectiveness”. Int J Health Policy Manag 6, 233236.CrossRefGoogle Scholar
Carlsson, P (2004) Health technology assessment and priority setting for health policy in Sweden. Int J Technol Assess Health Care 20, 4454.CrossRefGoogle ScholarPubMed
Doaee, S, Oliyaeemanesh, A, Nejati, M et al. . (2012) Establishment of health technology assessment in Iran. J Fam Reprod Health 6, 7378.Google Scholar
Doaee, S, Olyaeemanesh, A, Emami, S et al. . (2013) Development and implementation of health technology assessment: A policy study. Iran J Public Health 42, 5054.Google ScholarPubMed
Arab-Zozani, M, Jalilian, H, Oskouei, MM et al. . (2017) Implementing health technology assessment in Iran: A stakeholder analysis. BMJ Open 7(Suppl 1), A29–A30.Google Scholar
Olyaeemanesh, A, Doaee, S, Mohammadreza, M (2013) Health technology assessment in Islamic Republic of Iran. RaheSoraya 48, 21.Google Scholar
Arab-Zozani, M, Majdzadeh, R, Sarbakhsh, P et al. (2017) The attitude of health technology assessment students to their field of study and future career in Iran. IJER 4, 227231.Google Scholar
Mohtasham, F, Yazdizadeh, B, Zali, Z et al. . (2016) Health technology assessment in Iran: Barriers and solutions. Med J Islam Repub Iran 30, 321.Google ScholarPubMed
Olyaeemanesh, A, Doaee, S, Mobinizadeh, M et al. . (2014) Health technology assessment in Iran: Challenges and views. Med J Islam Repub Iran 28, 157.Google ScholarPubMed
Yazdizadeh, B, Shahmoradi, S, Majdzadeh, R et al. . (2016) Stakeholder involvement in health technology assessment at national level: A study from Iran. Int J Technol Assess Health Care 32, 181189.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Schematic structure of the Iranian health system.

Figure 1

Table 1. Number of domains, topics, and questions

Figure 2

Fig. 2. Work process of health technology assessment projects.

Figure 3

Fig. 3. Challenges of HTA in Iran.

Supplementary material: File

Arab-Zozani et al. supplementary material

Arab-Zozani et al. supplementary material

Download Arab-Zozani et al. supplementary material(File)
File 101.4 KB